ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)GlobeNewsWire • 09/06/22
Here's Why ProPhase Labs, Inc. (PRPH) is a Great Momentum Stock to BuyZacks Investment Research • 08/25/22
ProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/12/22
ProPhase Labs, Inc. (PRPH) Tops Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/11/22
ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern TimeGlobeNewsWire • 08/05/22
Strength Seen in ProPhase Labs, Inc. (PRPH): Can Its 8% Jump Turn into More Strength?Zacks Investment Research • 07/26/22
ProPhase Labs, Inc. (PRPH) Soars 9.1%: Is Further Upside Left in the Stock?Zacks Investment Research • 07/08/22
ProPhase Labs, Inc. (PRPH) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 06/29/22
ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and BiotechnologyGlobeNewsWire • 06/28/22
ProPhase Labs, Inc. (PRPH) Surges 7.6%: Is This an Indication of Further Gains?Zacks Investment Research • 06/22/22
Is ProPhase Labs (PRPH) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 06/13/22
Has ProPhase Labs (PRPH) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 05/26/22
ProPhase Labs, Inc. (PRPH) Moves to Strong Buy: Rationale Behind the UpgradeZacks Investment Research • 05/24/22
ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment ConferenceGlobeNewsWire • 05/18/22
ProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/13/22
ProPhase Labs, Inc. (PRPH) Tops Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/13/22
ProPhase Labs to Present at the Spring Into Action – Best Ideas Virtual Investor ConferenceGlobeNewsWire • 05/11/22